GSK Consumer Healthcare - Q1 CY13 results - Microsec

GSK Consumer Healthcare announced its Q1 CY13 results on 02 May 2013. The company's Net Sales increased by 17% YOY to 975 crore and its EBITDA increased by 11% YOY to INR206 crore. EBITDA Margin of the company decreased from 22.1% to 21.1% YOY. PAT of the company increased by 18% YOY to INR156 crore backed by increase in other income. At the CMP of INR4220, the stock discounts its CY13E of INR118 by 35x . We remain Neutral to the stock.

Shares of was last trading in BSE at Rs., up by Rs. or %. The stock hit an intraday high of Rs. and intraday low of Rs..

The total traded quantity was lakhs compared to 2 week average of lakhs.

Source : Equity Bulls

Keywords